期刊文献+
共找到91篇文章
< 1 2 5 >
每页显示 20 50 100
Intranasal delivery of nanostructured lipid carriers,solid lipid nanoparticles and nanoemulsions:A current overview of in vivo studies 被引量:9
1
作者 Cláudia pina Costa Joao Nuno Moreira +1 位作者 JoséManuel Sousa Lobo Ana Catarina Silva 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2021年第4期925-940,共16页
The management of the central nervous system(CNS)disorders is challenging,due to the need of drugs to cross the blood-brain barrier(BBB)and reach the brain.Among the various strategies that have been studied to circum... The management of the central nervous system(CNS)disorders is challenging,due to the need of drugs to cross the blood-brain barrier(BBB)and reach the brain.Among the various strategies that have been studied to circumvent this challenge,the use of the intranasal route to transport drugs from the nose directly to the brain has been showing promising results.In addition,the encapsulation of the drugs in lipid-based nanocarriers,such as solid lipid nanoparticles(SLNs),nanostructured lipid carriers(NLCs)or nanoemulsions(NEs),can improve nose-to-brain transport by increasing the bioavailability and site-specifc delivery.This review provides the state-of-the-art of in vivo studies with lipid-based nanocarriers(SLNs,NLCs and NEs)for nose-to-brain delivery.Based on the literature available from the past two years,we present an insight into the different mechanisms that drugs can follow to reach the brain after intranasal administration.The results of pharmacokinetic and pharmacodynamics studies are reported and a critical analysis of the differences between the anatomy of the nasal cavity of the different animal species used in in vivo studies is carried out.Although the exact mechanism of drug transport from the nose to the brain is not fully understood and its effectiveness in humans is unclear,it appears that the intranasal route together with the use of NLCs,SLNs or NEs is advantageous for targeting drugs to the brain.These systems have been shown to be more effective for nose-to-brain delivery than other routes or formulations with non-encapsulated drugs,so they are expected to be approved by regulatory authorities in the coming years. 展开更多
关键词 Nose-to-brain delivery Intranasal administration Nanostructured lipid carriers NLC Solid lipid nanoparticles SLN NANOEMULSIONS In vivo studies PHARMACOKINETIC PHARMACODYNAMICS
原文传递
Adipose tissue and vascular inflammation in coronary artery disease 被引量:8
2
作者 Enrica Golia Giuseppe Limongelli +11 位作者 Francesco Natale Fabio Fimiani Valeria Maddaloni pina Elvira Russo Lucia Riegler Renatomaria Bianchi Mario Crisci Gaetano Di Palma Paolo Golino Maria Giovanna Russo Raffaele Calabrò Paolo Calabrò 《World Journal of Cardiology》 CAS 2014年第7期539-554,共16页
Obesity has become an important public health issue in Western and developing countries,with well known metabolic and cardiovascular complications.In the last decades,evidence have been growing about the active role o... Obesity has become an important public health issue in Western and developing countries,with well known metabolic and cardiovascular complications.In the last decades,evidence have been growing about the active role of adipose tissue as an endocrine organ in determining these pathological consequences.As a consequence of the expansion of fat depots,in obese subjects,adipose tissue cells develope a phenotypic modification,which turns into a change of the secretory output.Adipocytokines produced by both adipocytes and adipose stromal cells are involved in the modulation of glucose and lipid handling,vascular biology and,moreover,participate to the systemic inflammatory response,which characterizes obesity and metabolic syndrome.This might represent an important pathophysiological link with atherosclerotic complications and cardiovascular events.A great number of adipocytokines have been described recently,linking inflammatory mileu and vascular pathology.The understanding of these pathways is crucial not only from a pathophysiological point of view,but also to a better cardiovascular disease risk stratification and to the identification of possible therapeutic targets.The aim of this paper is to review the role of Adipocytokines as a possible link between obesity and vascular disease. 展开更多
关键词 ADIPOCYTOKINES OBESITY METABOLIC syndrome CORONARY ARTERY disease Inflammation
下载PDF
Prevalence and dietetic management of mild gastrointestinal disorders in milk-fed infants 被引量:6
3
作者 D Infante pina X Badia Llach +1 位作者 B Ario-Armengol V Villegas Iglesias 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第2期248-254,共7页
AIM: To assess the prevalence of mild gastrointestinal disorders in milk-fed infants in paediatric practice, and to evaluate the effectiveness and satisfaction with dietetic treatment.METHODS: A cross-sectional epidem... AIM: To assess the prevalence of mild gastrointestinal disorders in milk-fed infants in paediatric practice, and to evaluate the effectiveness and satisfaction with dietetic treatment.METHODS: A cross-sectional epidemiological study was first carried out. A total of 285 paediatricians included 3487 children seen during a period of one week. In a second phase an observational, prospective and multicentre study was conducted and 2069 milk-fed infants with mild gastrointestinal disorders (colic, constipation, regurgitation and diarrhoea) were included. There was a baseline visit (start of treatment) and a final visit four weeks later. The effectiveness of the various Novalac formulas, as well as the satisfaction of the parents/tutors and paediatricians with the dietetic treatment were assessed at the final visit.RESULTS: The prevalence of mild gastrointestinal disorders was 27.8% of all paediatrician consultations (9.2%, 7.8%, 6.1% and 4.6% in relation to colic, constipation, regurgitation and diarrhoea, respectively). The several Novalac adapted milk formulas resolved 88.4% of the mild gastrointestinal disorders. Depending on the type of disorder, differences in response rate were observed. The highest effectiveness was recorded with respect to diarrhoea (92.6%), followed by constipation (91.6%), colic (87.6%) and regurgitation (81%). Overall, 91% of the paediatricians and 88.8% of the parents/tutors were satisfied or very satisfied with the Novalac adapted milk formulas.CONCLUSION: Mild gastrointestinal disorders show a high prevalence in paediatric practice. The Novalac adapted milk formulas have been shown to be effective in treating mild gastrointestinal disorders in milk-fed infants in the context of routine clinical practice. 展开更多
关键词 Mild gastrointestinal disorders PREVALENCE Adapted infant formulas Effectiveness SATISFACTION
下载PDF
Emerging role of liquid biopsy in rat sarcoma virus mutated metastatic colorectal cancer:A case report 被引量:1
4
作者 João Gramaça Isabel Gomes Fernandes +4 位作者 Carolina Trabulo Joana Gonçalves Rita Gameiro dos Santos Adriano Baptista Idília pina 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第1期234-243,共10页
BACKGROUND In patients with metastatic colorectal cancer(mCRC),the treatment options are limited and have been proved to be affected by rat sarcoma virus(RAS)mutational status.In RAS wild-type(wt)patients,the combinat... BACKGROUND In patients with metastatic colorectal cancer(mCRC),the treatment options are limited and have been proved to be affected by rat sarcoma virus(RAS)mutational status.In RAS wild-type(wt)patients,the combination of antiepidermal growth factor receptor(EGFR)monoclonal antibodies with chemotherapy(CT)is more effective than CT alone.On the other hand,RAS-mutated patients are not eligible for treatment with anti-EGFR antibodies.CASE SUMMARY Eleven patients with initially RAS-mutated mCRC were followed from diagnosis to May 2022.At the time of cell-free DNA determination,five patients had undergone one CT line,five patients had undergone two CT lines,and one patient had undergone three CT lines(all in combination with bevacizumab).At the second and third treatment lines[second line(2L),third line(3L)],patients with neo-RAS wt received a combination of CT and cetuximab.In neo-RAS wt patients treated with anti-EGFR,our findings indicated an increase in progression-free survival for both 2L and 3L(14.5 mo,P=0.119 and 3.9 mo,P=0.882,respectively).Regarding 2L overall survival,we registered a slight increase in neo-RAS wt patients treated with anti-EGFR(33.6 mo vs 32.4 mo,P=0.385).At data cut-off,two patients were still alive:A RAS-mutated patient undergoing 3L treatment and a neo-RAS wt patient who received 2L treatment with anti-EGFR(ongoing).CONCLUSION Our case series demonstrated that monitoring RAS mutations in mCRC by liquid biopsy may provide an additional treatment line for neo-RAS wt patients. 展开更多
关键词 Metastatic colorectal cancer Rat sarcoma virus mutational status Liquid biopsy Rat sarcoma virus wild-type Neo-rat sarcoma virus wild-type Anti-epidermal growth factor receptor therapy Case report
下载PDF
Design and current progress of the Apollon 10 PW project 被引量:5
5
作者 J.P.Zou C.Le Blanc +23 位作者 D.N.Papadopoulos G.Chériaux P.Georges G.Mennerat F.Druon L.Lecherbourg A.Pellegrina P.Ramirez F.Giambruno A.Fréneaux F.Leconte D.Badarau J.M.Boudenne D.Fournet T.Valloton J.L.Paillard J.L.Veray M.pina P.Monot J.P.Chambaret P.Martin F.Mathieu P.Audebert F.Amiranoff 《High Power Laser Science and Engineering》 SCIE CAS CSCD 2015年第1期32-35,共4页
The objective of the Apollon project is the generation of 10 PW peak power pulses of 15 fs at 1 shot/minute. In this paper the Apollon facility design, the technological challenges and the current progress of the proj... The objective of the Apollon project is the generation of 10 PW peak power pulses of 15 fs at 1 shot/minute. In this paper the Apollon facility design, the technological challenges and the current progress of the project will be presented. 展开更多
关键词 TITANIUM LASERS PW class facilities
原文传递
2018年全球新药研发报告-第1部分:新药和生物制剂(Ⅱ) 被引量:1
6
作者 Graul A I pina P +1 位作者 Cruces E Stringer M 《药学进展》 CAS 2019年第5期384-397,共14页
2018年全球首次获批或上市的新药和生物制剂共64种,达近10年来最大数量。同年,还有19种产品线拓展产品(即新适应证、新联合用药和新制剂等)获批,以及23种新产品和产品线拓展产品获批但在2018年12月31日前尚未上市。作为近年来的发展趋势... 2018年全球首次获批或上市的新药和生物制剂共64种,达近10年来最大数量。同年,还有19种产品线拓展产品(即新适应证、新联合用药和新制剂等)获批,以及23种新产品和产品线拓展产品获批但在2018年12月31日前尚未上市。作为近年来的发展趋势,抗肿瘤是上市药物最活跃的治疗领域,抗肿瘤药物占2018年全球获批或上市新药及生物制剂的25%。2018年首次上市8个同类首创新药(first- in-class),包括首个RNA干扰剂,3种不同类型的非血管收缩性抗偏头痛药物和抗降钙素基因相关肽(CGRP)单克隆抗体。2018年29种指定孤儿药的获批反映了被忽视疾病领域投资的持续增长。这在美国尤为突出,因为2018年美国有25种孤儿药获批上市。总体而言,美国是新药和生物制剂最活跃的市场,占2018年所有新上市产品的2/3。 展开更多
关键词 新药上市 新药批准 产品线拓展 新剂型 新适应证 新联合用药 孤儿药 同类首创新药
原文传递
抗血小板药物的多效性研究进展 被引量:1
7
作者 De pina Almeida Edmisa 刘学波 《同济大学学报(医学版)》 CAS 2018年第3期128-132,共5页
冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease,CAD)是由冠状动脉发生动脉粥样硬化而引起血管腔狭窄或阻塞,造成心肌缺血缺氧或发生坏死。抗血小板药物在CAD治疗中占据首要地位,目前常用于临床治疗的抗血小板药物... 冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease,CAD)是由冠状动脉发生动脉粥样硬化而引起血管腔狭窄或阻塞,造成心肌缺血缺氧或发生坏死。抗血小板药物在CAD治疗中占据首要地位,目前常用于临床治疗的抗血小板药物分别是口服环氧化酶-1(COX-1)抑制剂、口服P2Y12受体抑制剂以及磷酸二酯酶抑制剂。抗血小板药物除抗血小板聚集,还具有抗炎、抗动脉硬化、抗癌、改善冠状动脉痉挛、改善内皮功能等作用。本文就阿司匹林、氯吡格雷、替格瑞洛、双嘧达莫以及西洛他唑的多效性进行综述。 展开更多
关键词 阿司匹林 氯吡格雷 替格瑞洛 双嘧达莫 西洛他唑
下载PDF
2017年全球新药研发报告——第一部分:新药和生物制剂(Ⅳ) 被引量:1
8
作者 Graul A I pina P Stringer M 《药学进展》 CAS 2018年第7期554-560,I0001-I0004,共11页
2017年全球首次获批或上市的新药和生物制剂共113种,包括首次上市的52种新药和生物制剂,其中有7种为首创药物(first—in—class),即该药物具有全新作用机制并在全球首次获批并上市;36种产品线拓展产品(即新适应证、新联合用药和... 2017年全球首次获批或上市的新药和生物制剂共113种,包括首次上市的52种新药和生物制剂,其中有7种为首创药物(first—in—class),即该药物具有全新作用机制并在全球首次获批并上市;36种产品线拓展产品(即新适应证、新联合用药和新制剂等);以及2017年首次获批,但2017年12月31日前尚未上市的25种产品。美国是全球新药研发最活跃的市场,肿瘤是最为活跃的治疗领域。在制药和生物技术领域年度报告的第一部分中将深入报道这些新药和生物制剂的相关信息。 展开更多
关键词 新上市药物 新批准药物 延伸性新药 首创药物
原文传递
2017年全球新药研发报告——第一部分:新药和生物制剂(Ⅱ) 被引量:1
9
作者 Graul A I pina P Stringer M 《药学进展》 CAS 2018年第5期394-398,共5页
2017年全球首次获批或上市的新药和生物制剂共113种,包括酋次上市的52种新药和生物制剂,其中有7种为首创药物(first-inclass),即该药物具有全新作用机制并在全球首次获批并上市:36种产品线拓展产品(即新适应证、新联合用药和新... 2017年全球首次获批或上市的新药和生物制剂共113种,包括酋次上市的52种新药和生物制剂,其中有7种为首创药物(first-inclass),即该药物具有全新作用机制并在全球首次获批并上市:36种产品线拓展产品(即新适应证、新联合用药和新制剂等):以及2017年首次获批、但2017年12月31日前尚未上市的25种产品。美国是全球新药研发最活跃的市场,肿瘤是最为活跃的治疗领域。在制药和生物技术领域年度报告的第—部分中,将深入报道这些新药和生物制剂的相关信息。 展开更多
关键词 新上市药物 新批准药物 延伸性新药 首创药物
原文传递
2016年全球新药研发报告--第一部分:新药和生物制品(Ⅰ) 被引量:1
10
作者 Graul A I pina P +1 位作者 Cruces E Stringer M 《药学进展》 CAS 2017年第4期305-312,共8页
2016年全球首次批准或上市的新药和生物制品接近90种,其中包括重要的延伸性新药。与往年相比,这一数字相对较低。2016年全球首次上市的新药和新生物制品共44种,比前一年减少近10%。新上市药物中,7种药物为首创药物,即具有全新作用机制,... 2016年全球首次批准或上市的新药和生物制品接近90种,其中包括重要的延伸性新药。与往年相比,这一数字相对较低。2016年全球首次上市的新药和新生物制品共44种,比前一年减少近10%。新上市药物中,7种药物为首创药物,即具有全新作用机制,并在全球首次通过批准并上市的新药。此外,2016年共批准了23种延伸性新药(即新配方、新联合用药和新适应证)。另有21种产品于2016年首次获批,但截至2016年12月15日尚未上市。在制药和生物技术领域年度报告的第一部分中,将深入报道这些新药的相关信息。 展开更多
关键词 新上市药物 新批准药物 延伸性新药 首创药物
原文传递
2019年全球新药研发报告(Ⅰ) 被引量:1
11
作者 Graul A I pina P +1 位作者 Tracy M Sorbera L 《药学进展》 CAS 2020年第5期395-400,共6页
通过对全球药品市场新获批和新上市的药物进行年度综述,重点内容包括:截至目前,在囊性纤维化治疗中应用最广泛的Trikafta的获批和上市;首款常规(非应急)接种用的埃博拉疫苗的获批;全球首款疟疾疫苗在3个非洲国家的试点推广;一种新型多... 通过对全球药品市场新获批和新上市的药物进行年度综述,重点内容包括:截至目前,在囊性纤维化治疗中应用最广泛的Trikafta的获批和上市;首款常规(非应急)接种用的埃博拉疫苗的获批;全球首款疟疾疫苗在3个非洲国家的试点推广;一种新型多药耐药细菌感染治疗药物的获批;首款阿尔茨海默病原研药在中国的获批上市,结束全球10余年来相关领域无新药上市的历史。随着多款新型免疫检查点抑制剂和抗体药物偶联物的恶性肿瘤适应证相继获批,证实了生物制药行业对恶性肿瘤免疫疗法的投入热情持续上涨。2019年最引人瞩目的趋势是美国FDA授予了创纪录数量的加速审批,其中多项审评的批准早于预期批准日期多达数月。 展开更多
关键词 新药获批 产品线拓展产品 新剂型 新适应证 新联合用药 孤儿药 同类首创新药 加速审批
原文传递
Risk Factors for Severity and Mortality of Patients Hospitalized for COVID-19 during the 3rd Wave of the Epidemic-Sao Tome and Principe
12
作者 Eula Carvalho Bakissy pina +3 位作者 Rosa Neto Wrceley Lima Vanderley Bandeira Leonilde Carvalho 《Advances in Infectious Diseases》 2023年第2期303-322,共20页
Rationale: In the literature, some risk factors for severity and mortality from COVID-19 have been indicated. However, these factors can change, depending on the characteristics of the population and health services. ... Rationale: In the literature, some risk factors for severity and mortality from COVID-19 have been indicated. However, these factors can change, depending on the characteristics of the population and health services. In this sense, longitudinal studies can be useful for understanding local realities and subsidizing health actions based on these realities. Objective: To analyze the risk factors for severity and death in hospitalized patients with COVID-19. Methods: A retrospective cohort of patients with COVID-19 hospitalized from August 1 to October 16, 2021 (3<sup>rd</sup> wave of the pandemic), notified by the Department of Epidemiological Surveillance of Sao Tome and Principe. We employed measures of strength of associations for the analysis of exposure risk factors. Results: We analyzed 110 hospitalized patients (31.8% severe-critical and 68.2% non-severe). The risk factors for severe forms of COVID-19 were: being aged ≥60 years (RR = 3.3), being male (RR = 2), having comorbidities (RR = 2) and the risk increases to 10-fold for multicomorbidities, with emphasis on obesity, neoplasia, skin-muscle-surgical infection, dementia and to some degree CVD. 62.9% of patients with severe forms of the disease were not vaccinated. Risk factors for death among hospitalized and severe/critical cases, respectively, were having comorbidities (RR = 8 and 2.4) multicomorbidities (RR = 10 and 2.8 for those with 2 comorbidities and RR = 33.3 and 4 for those with 3 or 4 comorbidities), especially diabetes, dementia, neoplasia, cutaneous-muscular infection, and obesity. Although CVD was not associated with risk factors for death, these were the most frequently found among the severely hospitalized and deaths. In addition, important risk factors associated with death were not using corticoids (RR = 3.3, 230-fold risk) and not using anticoagulants-heparin (RR = 1.3, 30% risk) more compared to the severe cases that did use them. Most of the patients who died (63.2%) were not vaccinated. Moreover, having only 1 dose of the vaccine wa 展开更多
关键词 Covid-19 3rd Wave of the Epidemic Risk Factors Death SEVERITY Sao Tomé and Principe
下载PDF
2018年全球新药研发报告——第2部分:趋势与挑战(V) 被引量:1
13
作者 Graul A I Dulsat C +2 位作者 pina P Cruces E Tracy M 《药学进展》 CAS 2019年第9期701-715,共15页
从制药产业的全局着眼,重点探讨2018年那些最令人瞩目的事件,包括埃博拉疫情在刚果的大规模持续性爆发,基因编辑技术CRISPR的潜在应用及滥用等。与往年一样,报告还将继续回顾孤儿药的开发情况,新的监管支持政策,如欧盟的优先药物制度(PR... 从制药产业的全局着眼,重点探讨2018年那些最令人瞩目的事件,包括埃博拉疫情在刚果的大规模持续性爆发,基因编辑技术CRISPR的潜在应用及滥用等。与往年一样,报告还将继续回顾孤儿药的开发情况,新的监管支持政策,如欧盟的优先药物制度(PRIME)和日本的Sakigake制度,企业研发管线的损耗,以及值得关注的制药/生物技术公司的兼并与收购。最后,报告还对2019年即将获批的新药进行了预测。 展开更多
关键词 CRISPR-Cas9 埃博拉 孤儿药 Sakigake 优先药物制度 兼并与收购 研发管线
原文传递
Echography in brain imaging in intensive care unit: State of the art 被引量:3
14
作者 Anselmo Caricato Sara Pitoni +3 位作者 Luca Montini Maria Grazia Bocci pina Annetta Massimo Antonelli 《World Journal of Radiology》 CAS 2014年第9期636-642,共7页
Transcranial sonography(TCS)is an ultrasound-based imaging technique,which allows the identification of several structures within the brain parenchyma.In the past it has been applied for bedside assessment of differen... Transcranial sonography(TCS)is an ultrasound-based imaging technique,which allows the identification of several structures within the brain parenchyma.In the past it has been applied for bedside assessment of different intracranial pathologies in children.Pres-ently,TCS is also used on adult patients to diagnose intracranial space occupying lesions of various origins,intracranial hemorrhage,hydrocephalus,midline shift and neurodegenerative movement disorders,in both acute and chronic clinical settings.In comparison with conventional neuroimaging methods(such as com-puted tomography or magnetic resonance),TCS has the advantages of low costs,short investigation times,repeatability,and bedside availability.These noninva-sive characteristics,together with the possibility of of-fering a continuous patient neuro-monitoring system,determine its applicability in the monitoring of multiple emergency and non-emergency settings.Currently,TCS is a still underestimated imaging modality that requires a wider diffusion and a qualified training process.In this review we focused on the main indications of TCSfor the assessment of acute neurologic disorders in in-tensive care unit. 展开更多
关键词 BRAIN SONOGRAPHY TRANSCRANIAL SONOGRAPHY ULTRASOUNDS CEREBRAL SONOGRAPHY BRAIN imaging Hy-drocephalus CEREBRAL hemorrhage
下载PDF
Interpretable discovery of semiconductors with machine learning 被引量:2
15
作者 Hitarth Choubisa Petar Todorović +5 位作者 Joao M.pina Darshan H.Parmar Ziliang Li Oleksandr Voznyy Isaac Tamblyn Edward H.Sargent 《npj Computational Materials》 SCIE EI CSCD 2023年第1期1150-1160,共11页
Machine learning models of material properties accelerate materials discovery,reproducing density functional theory calculated results at a fraction of the cost1–6.To bridge the gap between theory and experiments,mac... Machine learning models of material properties accelerate materials discovery,reproducing density functional theory calculated results at a fraction of the cost1–6.To bridge the gap between theory and experiments,machine learning predictions need to be distilled in the form of interpretable chemical rules that can be used by experimentalists.Here we develop a framework to address this gap by combining evolutionary algorithm-powered search with machine-learning surrogate models.We then couple the search results with supervised learning and statistical testing.This strategy enables the efficient search of a materials space while providing interpretable design rules.We demonstrate its effectiveness by developing rules for the design of direct bandgap materials,stable UV emitters,and IR perovskite emitters.Finally,we conclusively show how DARWIN-generated rules are statistically more robust and applicable to a wide range of applications including the design of UV halide perovskites. 展开更多
关键词 preta LEARNING PEROVSKITE
原文传递
Synthesis and Evaluation of Corrosion Inhibiting Activity of New Molecular Hybrids Containing the Morpholine, 1,4-Naphthoquinone, 7-Chloroquinoline and 1,3,5-Triazine Cores
16
作者 Regina Westphal Jorge Welton de Souza pina +5 位作者 Juliana Panceri Franco Josimar Ribeiro Maicon Delarmelina Rodolfo Goetze Fiorot José Walkimar de Mesquita Carneiro Sandro José Greco 《Advances in Chemical Engineering and Science》 2020年第4期378-398,共21页
Three molecules containing morpholine, 1,4-naphthoquinone, 7-chloroquinoline<span><span><span><span><span style="font-family:;" "=""> <span style="font-fa... Three molecules containing morpholine, 1,4-naphthoquinone, 7-chloroquinoline<span><span><span><span><span style="font-family:;" "=""> <span style="font-family:Verdana;">and 1,3,5-triazine cores, scaffolds with recognized ant</span><span style="font-family:Verdana;">i-corrosive activity, were synthesized and had their anticorrosive activity evaluated through potentiodynamic polarization and electrochemical impedance studies. Both studies </span><span style="font-family:Verdana;">were conducted in a simulated production water medium containing </span></span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">150</span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">,</span></span></span></span></span><span><span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">000 mg·L</span><sup><span style="font-family:Verdana;"><span style="font-size:10.0pt;font-family:"">-</span>1</span></sup><span style="font-family:Verdana;"> Cl</span><sup><span style="font-family:Verdana;"><span style="font-size:10.0pt;font-family:"">-</span></span></sup></span></span></span></span></span><span><span><span><span><span style="font-family:;" "=""> </span></span></span></span></span><span><span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">and 5 mg·L</span><sup><span style="font-family:Verdana;"><span style="font-size:10.0pt;font-family:"">-</span>1</span></sup><span style="font-family:Verdana;"> S</span><sup><span style="font-family:Verdana;">2<span style="font-size:10.0pt;font-family:"">-</span></span></sup><span style="font-family:Verdana;">. Corrosion inhibition efficiency ranged from 6</span></span></span></span></span></span><span style="font-family:Verdana;"><span style=" 展开更多
关键词 CORROSION Density Functional Calculations Eletrochemical Impedance Spectroscopy HETEROCYCLES Polarization
下载PDF
2016年全球新药研发报告--第一部分:新药和生物制品(Ⅲ)
17
作者 Graul A I pina P +1 位作者 Cruces E Stringer M 《药学进展》 CAS 2017年第7期549-555,共7页
2016年全球首次批准或上市的新药和生物制品接近90种,其中包括重要的延伸性新药。与往年相比,这一数字相对较低。2016年全球首次上市的新药和新生物制品共44种,比前一年减少近10%。新上市药物中,7种药物为首创药物,即具有全新作用机制,... 2016年全球首次批准或上市的新药和生物制品接近90种,其中包括重要的延伸性新药。与往年相比,这一数字相对较低。2016年全球首次上市的新药和新生物制品共44种,比前一年减少近10%。新上市药物中,7种药物为首创药物,即具有全新作用机制,并在全球首次通过批准并上市的新药。此外,2016年共批准了23种延伸性新药(即新配方、新联合用药和新适应证)。另有21种产品于2016年首次获批,但截至2016年12月15日尚未上市。在制药和生物技术领域年度报告的第一部分中,将深入报道这些新药的相关信息。 展开更多
关键词 新上市药物 新批准药物 延伸性新药 首创药物
原文传递
Factors Associated with Umbilical Cord Stump Healing Practices: Literature Review
18
作者 Marilya Rodrigues Reis Marília Cordeiro de Sousa +12 位作者 Lays de Souza Silva Lívia Roberta Rodrigues Conceição Marcela de Andrade Silvestre Camila de pina Soares Sudário Renata Calciolari Rossi Janaína Valadares Guimarães Thaíla Corrêa Castral Karina Machado Siqueira Pedro Teixeira Meireles Bruno Belmonte Martineli Gomes George Kemil Abdalla Douglas Reis Abdalla Ana Karina Marques Salge 《Open Journal of Obstetrics and Gynecology》 2020年第8期1067-1078,共12页
<strong>Objective</strong>:<span style="font-family:""><span style="font-family:Verdana;"> To analyze the evidence in the evolution of scientific production on the fact... <strong>Objective</strong>:<span style="font-family:""><span style="font-family:Verdana;"> To analyze the evidence in the evolution of scientific production on the factors associated with curative practices of the umbilical stump. </span><b><span style="font-family:Verdana;">Materials and Methods:</span></b><span style="font-family:Verdana;"> The study data collection took place in April 2017. The electronic databases used to search the articles were: PubMed (National Library of Medicine and National Institutes of Health) and VHL (Virtual Health Library). We used the keywords “perinatal care”, “umbilical cord”, “patient care team”, “neonatology”, “newborn”, in the Portuguese, English and Spanish languages, accompanied by the expression AND and selected through DeCS (Descriptors in Health Sciences). </span><b><span style="font-family:Verdana;">Results: </span></b><span style="font-family:Verdana;">A final sample of 9 articles was obtained from the PubMed and VHL databases, which met the inclusions criteria. It has been found that traditional umbilical stump care practices are still present in many communities, however, have been replaced by appropriate practices, the most recommended being: chlorhexidine 4% sanitation, soap and water and alcohol antisepsis 70%. </span><b><span style="font-family:Verdana;">Conclusions: </span></b><span style="font-family:Verdana;">There is a need for multi-professional involvement, approaching these women since pregnancy, with detailed information and accessible language about proper care with the newborn and the umbilical stump.</span></span> 展开更多
关键词 Perinatal Care The Umbilical Cord Patient Care Team NEONATOLOGY NEWBORN
下载PDF
Surgical Excision of Ischiorectal Fossa Tumors
19
作者 Javier Die Trill Juan Carlos García +5 位作者 Irene Moreno Juan Diego pina Estela Tobaruela Jose Barquin Juan Ocaña Antonio Rey 《Surgical Science》 2016年第10期461-465,共6页
Background: Ischiorectal Fossa Tumors are rare and their management has not been protocolized. Patients: We retrospectively review four consecutive cases treated in our department, from January 2015 to July 2015. All ... Background: Ischiorectal Fossa Tumors are rare and their management has not been protocolized. Patients: We retrospectively review four consecutive cases treated in our department, from January 2015 to July 2015. All of them were discussed in a multidisciplinary team meeting. None of them were secondary to an inflammatory process. Results: A Magnetic Resonance Imaging was performed in all the four patients, and as it was not a malignant diagnosis made in any of them, we proceeded to resecate the lesions. None biopsies were performed and the benign diagnoses were confirmed by the pathologist. All the patients underwent a local posterior or perineal approach, because all the lesions (epidermoid cyst, hamartoma, lipoma and an aggressive angiomyxoma) were localized purely in the ischiorectal fossa, under the levator ani muscle and not invading any adjacent structures. In all of them, an R0 resection was performed. Conclusions: Ischiorectal fossa tumors are rare and there are few cases already published. Non-inflammatory lesions located in the ischiorectal fossa, with none invasion of rectum or levator ani muscle, are mainly benign lesions prone to their complete excision by a posterior approach. Biopsy is not always necessary unless there’s a suspicion of a malignancy or invasion of adjacent structures, and only in that case a biopsy should be made, because in some of them, a neo-adjuvant treatment can be useful to reduce the tumor and to perform an R0 resection. 展开更多
关键词 Ischiorectal Fossa Tumors Aggressive Angiomyxoma
下载PDF
Acute Hemorrhagic Fever: Clinical, Epidemiological and Laboratory Aspects in São Toméand Príncipe
20
作者 Eula Carvalho Didiena Vilhete +7 位作者 Clara Assunção Ana Silva Jessica Vicente Ana Cristina Cleiser Vagente Francelina Costa Celdidy Monteiro Bakissi pina 《Advances in Infectious Diseases》 CAS 2022年第4期721-744,共24页
Background: In the last 6 months, cases of acute hemorrhagic fever (AHF) have been recorded in Sao Tome and Principe (STP). Objective: To identify the clinical, epidemiological and laboratory parameters associated wit... Background: In the last 6 months, cases of acute hemorrhagic fever (AHF) have been recorded in Sao Tome and Principe (STP). Objective: To identify the clinical, epidemiological and laboratory parameters associated with AHF cases found in patients hospitalized in STP. Methods: Descriptive and quantitative analysis of AHF cases hospitalized in STP in the period December 2021 to May 19, 2022 through the variables: demographic data;clinical data;laboratory data and clinical outcome. Results: Analyzed 18 of 22 AHF cases, 50% of them male, mean age 33.7 years, 85.7% residing in the 2 largest districts of the country, 66.7% rural workers, administrative near maritime areas, sailors and domestics. 66.7% were healthy individuals. ≥50% had a fever, asthenia/weakness, myalgia, headache, lethargy, nausea, vomiting, and diarrhea. 22.2% to 33.3% had retro-orbital pain, abdominal pain, decreased consciousness, dyspnea/hypoxia, and cough. In a smaller register (5.6% - 11.1%), exanthema, convulsion, arthralgia, low back pain, chills, and chest pain. Bleeding from the digestive tract was found in 72.2%, followed by vaginal (33.3%), urethral (27.8%), nasal (22.2%), and oral (16.7%). 50% had laboratory confirmation for dengue, and another 50% with suspected clinical diagnosis without laboratory confirmation of the etiologic agent. Despite hemorrhage, 66.7% of confirmed cases were hemodynamically non-severe, and 88.9% of suspected cases were severe. Coinfection with malaria is evidenced in 11.1% of cases. 72.2% recovered and 27.8% died (deaths in 55.5% of suspected cases). Case deaths were male (100%), resident foreigners (40%), tool store employees, sailors and students, healthy (80%), and residing in the largest district in the country (60%). All deaths were hospitalized in serious condition, 80% were hospitalized for hemorrhage and shock, with bleeding arising between day 4 - 5 of illness in 60% and hospitalization on day 5 of illness. 60% died within ≤24 hours of hospitalization. 80% died from shock and multi-organ dysfunctio 展开更多
关键词 Acute Hemorrhagic Fever Viral Hemorrhagic Fever DENGUE São Tomé and Príncipe HOSPITALIZATION Epidemic Dr. Ayres de Menezes Hospital
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部